PathAI, maker of AI-enabled pathology products, announced Friday it was partnering with pharma and diagnostics giant Roche.
The strategic partnership will allow PathAI to develop and distribute its AI pathology tech through Roche’s uPath enterprise software, a workflow platform for labs.
The collaboration will begin with distributing PathAI’s research-use-only algorithms through the cloud...
Digital pathology startup Proscia landed $23 million in Series B funding. The latest round was led by Scale Venture Partners with participation from Hitachi Ventures.
This comes roughly two years after the company closed its $8.5 million Series A round of funding.
WHAT THEY DO
The company’s main software platform is called Concentriq, which focuses on computational pathology. The tech uses...
Computational pathology platform Paige scored an additional $5 million from Goldman Sachs this week, closing its Series B funding at $50 million – exactly double its Series A funding amount.
As part of the news, Paige announced that David Castelblanco, managing director at Goldman Sachs, will be joining its board of directors.
In December, the company announced its initial $45 million round that...
This morning the AI-enabled diagnostic and treatment platform Paige, formerly called Paige.AI, announced a $45 million Series B funding round. The latest raise was led by Healthcare Venture Partners with participation from Breyer Capital, Kenan Turnacioglu and other funders.
Today the company has $70 million in investments. This latest round comes roughly two years after the company closed a $25...
Ibex Medical Analytics, an Israel-based startup focused on AI-powered cancer diagnostics and the KSM Research and Innovation Institute at Maccabi Healthcare Services, announced the deployment of the Ibex Second Read System for breast at Maccabi's pathology institute, the largest pathology lab in Israel.
WHAT IT DOES
According to Ibex, their Second Read System is the first-ever system that detects...
Ibex Medical Analytics, an Israel-based startup founded in 2016 which is developing their own AI-driven computational pathology cancer diagnosis system, recently completed an $11M Series A funding round led by aMoon Fund. Additional investors in the round include Kamet Ventures, an investment arm of AXA Insurance, one of the largest global health insurance providers, 83North, a global venture...
